Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry
Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry
Increasing Volume and Decreasing Value
RELEASE DATE
09-Jan-2014
09-Jan-2014
REGION
Global
Global
Research Code: NBAE-01-00-00-00
SKU: LS00111-GL-MR_16952
$4,950.00
In stock
SKU
LS00111-GL-MR_16952
Description
This research service analyzes merger and acquisition trends in the global pharmaceutical and biotechnology industry, along with specific merger and acquisition deals in this industry. Analysis is based on the number of and the average value of these deals. Merger and acquisition trends are also observed and analyzed based on the geographic region and buyer type. This research study delves into the nature of cross-border deals and also explores various deal multiples such as enterprise value, percent stakes sought, and target stock premium analysis of target companies. The study concludes with 5 big predictions.
Table of Contents
Preface
- Title, Research Team, and Contents
Executive Summary
- Executive Summary and Implications
Introduction
- Introduction
The Key Rationale for M&A
- Overview
Key M&A Statistics
- Overview
Geographic Analysis
- Overview
Cross-border Deal Analysis—Buyer’s Perspective for Asia-Pacific, Europe, and North America
- Overview
Sectorial Analysis—Pharmaceutical
- Overview
Sectorial Analysis—Biotechnology
- Overview
Percent Stake Sought and Target Stock Premium Analysis
- Overview
Conclusion
- The 5 Big Conclusions
Appendix
- Additional Information
The Frost & Sullivan Story
- The Frost & Sullivan Story
Popular Topics
This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is covered into four broad segments, namely by products, by technology and by application. The study covers various areas of interest such as regulatory policies within stem cell research, key business updates, analysis of risk factors, and strategic recommendations. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global stem cell market have been included.
No Index | No |
---|---|
Podcast | No |
Author | Saneesh Edacherian |
WIP Number | NBAE-01-00-00-00 |
Keyword 1 | pharmaceutical |
Keyword 2 | biotechnology |
Keyword 3 | Merger and Acquisition |
Is Prebook | No |